A detailed history of Nebula Research & Development LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 4,705 shares of KRYS stock, worth $775,525. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,705
Previous 1,192 294.71%
Holding current value
$775,525
Previous $219 Million 291.25%
% of portfolio
0.1%
Previous 0.04%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$174.7 - $213.66 $613,721 - $750,587
3,513 Added 294.71%
4,705 $856 Million
Q2 2024

Aug 14, 2024

BUY
$153.12 - $183.64 $182,519 - $218,898
1,192 New
1,192 $219 Million
Q2 2023

Aug 14, 2023

BUY
$78.48 - $130.32 $417,906 - $693,954
5,325 New
5,325 $625 Million

Others Institutions Holding KRYS

About Krystal Biotech, Inc.


  • Ticker KRYS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,664,300
  • Market Cap $4.23B
  • Description
  • Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...
More about KRYS
Track This Portfolio

Track Nebula Research & Development LLC Portfolio

Follow Nebula Research & Development LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nebula Research & Development LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nebula Research & Development LLC with notifications on news.